| Ticker Symbol: | NVS |
|---|---|
| Exchange: | NYSE |
| Contact Info: | Lichtstrasse 35 Basel 877 999-8850 |
| CEO/President: | Hans- J¿¿rg Rudloff |
| Industry: | Medical - Drugs / Standard Industry Code: 2834 |
| Description: | Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work. |
| Shares Outstanding: | 2,273,500 (000) | Market Value: | 120,724,424 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 11.95% | Number of Inst.Shareholders: | 0.01% |
| Last Quarter Sales: | 10726.00 ($Mil.) | Last Quarter Net Income: | 2266.00 ($Mil.) |
| Last Quarter EPS: | 0.99 | P/E Ratio: | 10 |
| Most Recent Earnings: | 0.99 on 07/17/08 | Earnings Per Share: | 5.39 |
| Most Recent Split: | Annual Dividend Rate: | 1.3 | |
| Most Recent Dividend: | 1.303 on 02/26/08 | Annual Dividend Yield: | 2.44% |


| PFIZER INC | -18.50 | 18.67 | |
| MERCK CO INC | -32.60 | 34.17 | |
| JOHNSON AND JOH | +17.90 | 70.45 | |
| SCHERING PLOUGH | -29.30 | 19.16 | |
| BRISTOL MYERS S | -18.00 | 21.50 |
